This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Samsung Display Co., Ltd., The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2026
Title: Innovations of Sang Ju Lee in Radiopharmaceuticals
Introduction
Sang Ju Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 6 patents. His work focuses on innovative methods and compositions that enhance medical imaging and treatment.
Latest Patents
One of his latest patents involves radiopharmaceuticals and a composition for thrombus imaging. This invention includes a compound represented by a specific formula, which acts as a chelating agent labeled with a metallic radioisotope. The thrombus imaging composition utilizes this compound as an active ingredient, providing advancements in medical imaging techniques. Another notable patent is a method for preparing fluorine-18 eluent with adjusted pH, which allows for the labeling of fluorine-18, a crucial radioisotope. This method enables the production of fluorine-18-labeled radioactive medical supplies with high yield and stability.
Career Highlights
Sang Ju Lee has worked with notable companies such as Samsung Display Co., Ltd. and The Asan Foundation. His experience in these organizations has contributed to his expertise in the field of radiopharmaceuticals and medical imaging technologies.
Collaborations
He has collaborated with talented individuals, including Hye Won Hyeon and Young Jae Jeon, who have contributed to his innovative projects and research.
Conclusion
Sang Ju Lee's contributions to the field of radiopharmaceuticals demonstrate his commitment to advancing medical technology. His innovative patents and collaborations highlight his role as a leading inventor in this critical area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile